Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment

Beneficial effects of upadacitinib in the treatment of atopic dermatitis (AD) in patients who were unresponsive to dupilumab therapy have been described. In this study AD lesions resistant to dupilumab and localized in sensitive and visible areas showed a marked improvement with upadacitinib therapy.